Nov-01-24 08:00AM
|
|
Oct-31-24 02:02PM
|
|
Oct-30-24 10:01AM
|
|
Oct-29-24 08:00AM
|
|
Oct-23-24 08:00AM
|
|
10:53PM |
Loading… |
Oct-11-24 10:53PM
|
|
Oct-09-24 03:36PM
|
|
Sep-27-24 09:00PM
|
|
Sep-06-24 08:00AM
|
|
Aug-09-24 04:30PM
|
|
07:39AM
|
|
Aug-01-24 04:00PM
|
(Investor's Business Daily) +13.04% |
Jul-31-24 09:56PM
|
|
06:45PM
|
|
04:05PM
|
|
08:00AM |
Loading… |
08:00AM
|
|
Jul-30-24 08:00AM
|
|
Jul-25-24 08:00AM
|
|
Jul-23-24 07:03AM
|
(Pharmaceutical Technology) |
Jul-17-24 08:00AM
|
|
Jul-01-24 08:00AM
|
|
Jun-24-24 08:00AM
|
|
Jun-12-24 08:00AM
|
|
Jun-07-24 05:00PM
|
|
May-28-24 01:00AM
|
|
May-21-24 10:57AM
|
|
May-20-24 08:30AM
|
|
May-16-24 02:54AM
|
|
02:54AM
|
|
May-15-24 08:30AM
|
|
06:55PM |
Loading… |
May-10-24 06:55PM
|
|
09:10AM
|
|
May-08-24 11:09AM
|
|
07:24AM
|
(Thomson Reuters StreetEvents) |
03:53AM
|
|
May-07-24 08:58PM
|
|
06:35PM
|
|
05:46PM
|
|
04:05PM
|
|
May-02-24 07:37AM
|
|
Apr-23-24 04:30PM
|
|
Apr-21-24 10:39AM
|
|
Apr-17-24 04:05PM
|
|
Apr-12-24 04:05PM
|
|
Mar-26-24 08:00AM
|
|
Mar-14-24 07:04AM
|
|
Mar-13-24 09:55AM
|
|
Mar-11-24 07:00AM
|
|
Mar-08-24 04:05PM
|
|
03:24PM
|
|
12:30PM
|
(Thomson Reuters StreetEvents) |
Mar-07-24 10:34PM
|
|
09:53PM
|
|
04:05PM
|
|
Mar-04-24 08:28PM
|
|
Mar-01-24 08:30AM
|
|
Feb-27-24 08:30AM
|
|
Feb-22-24 04:30PM
|
|
Feb-09-24 04:05PM
|
|
Feb-02-24 09:10PM
|
|
Jan-16-24 05:28PM
|
|
Jan-12-24 04:23PM
|
|
Jan-09-24 06:21PM
|
|
Jan-04-24 04:05PM
|
|
Dec-20-23 08:00AM
|
|
Dec-08-23 04:30PM
|
|
Nov-13-23 09:08AM
|
|
Nov-10-23 05:16PM
|
|
Nov-07-23 04:16PM
|
|
Nov-06-23 08:45AM
|
|
Nov-01-23 08:45AM
|
|
Oct-25-23 08:45AM
|
|
08:45AM
|
|
Oct-08-23 06:41PM
|
|
Sep-29-23 04:05PM
|
|
Sep-13-23 04:10PM
|
|
Sep-09-23 01:03PM
|
|
Sep-03-23 05:29AM
|
|
Aug-29-23 08:45AM
|
|
Aug-27-23 07:20PM
|
|
Aug-23-23 06:53PM
|
|
Aug-21-23 08:45AM
|
|
Aug-08-23 09:15AM
|
|
08:45AM
|
|
Aug-02-23 05:45PM
|
|
04:05PM
|
|
Jul-27-23 11:42AM
|
|
08:45AM
|
|
Jul-26-23 10:02AM
|
|
08:45AM
|
|
Jul-19-23 08:45AM
|
|
Jul-15-23 07:30AM
|
|
Jun-29-23 09:00AM
|
|
Jun-22-23 08:45AM
|
|
Jun-08-23 04:05PM
|
|
Jun-02-23 06:38AM
|
|
May-16-23 01:44PM
|
|
May-09-23 05:25PM
|
|
04:01PM
|
|
04:01PM
|
|
|
|
|
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Beaver Sandra | Chief Financial Officer | Sep 06 '24 | Sale | 14.98 | 3,276 | 49,074 | 148,502 | Sep 06 09:45 PM | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Aug 30 '24 | Sale | 15.85 | 5,631 | 89,251 | 82,375 | Sep 04 04:14 PM | MOATAZEDI DAVID | See Remarks | Jun 06 '24 | Option Exercise | 7.28 | 175,940 | 1,280,843 | 709,289 | Jun 06 07:01 PM | MOATAZEDI DAVID | See Remarks | Jun 05 '24 | Option Exercise | 5.46 | 155,278 | 847,818 | 688,627 | Jun 06 07:01 PM | MOATAZEDI DAVID | See Remarks | Jun 06 '24 | Sale | 12.59 | 175,940 | 2,214,486 | 533,349 | Jun 06 07:01 PM | MOATAZEDI DAVID | See Remarks | Jun 05 '24 | Sale | 12.92 | 155,278 | 2,006,456 | 533,349 | Jun 06 07:01 PM | MOATAZEDI DAVID | See Remarks | Jun 04 '24 | Sale | 12.73 | 140,214 | 1,784,686 | 533,349 | Jun 06 07:01 PM | Malik Vikram | Director | Jun 03 '24 | Sale | 12.96 | 7,500 | 97,203 | 246,514 | Jun 05 09:30 PM | GILL DAVID N | Director | May 14 '24 | Sale | 12.60 | 6,718 | 84,654 | 33,964 | May 15 05:20 PM | GILL DAVID N | Director | May 13 '24 | Sale | 12.72 | 3,643 | 46,356 | 40,682 | May 15 05:20 PM | Malik Vikram | Director | May 13 '24 | Sale | 12.93 | 28,000 | 362,012 | 254,014 | May 15 05:19 PM | MOATAZEDI DAVID | See Remarks | May 10 '24 | Sale | 12.72 | 16,051 | 204,127 | 673,563 | May 14 08:56 PM | Avelar Rui | See Remarks | May 10 '24 | Sale | 12.72 | 3,441 | 43,761 | 368,847 | May 14 08:56 PM | Beaver Sandra | Chief Financial Officer | May 10 '24 | Sale | 12.72 | 2,423 | 30,814 | 151,778 | May 14 08:55 PM | MOATAZEDI DAVID | See Remarks | Mar 27 '24 | Sale | 13.86 | 6,236 | 86,431 | 689,614 | Mar 29 07:08 PM | Avelar Rui | See Remarks | Mar 19 '24 | Sale | 13.92 | 27,603 | 384,350 | 372,288 | Mar 21 06:09 PM | Beaver Sandra | Chief Financial Officer | Mar 19 '24 | Sale | 13.92 | 5,672 | 78,978 | 154,201 | Mar 21 06:09 PM | MOATAZEDI DAVID | See Remarks | Mar 19 '24 | Sale | 13.92 | 96,566 | 1,344,604 | 695,850 | Mar 21 06:08 PM | MOATAZEDI DAVID | See Remarks | Feb 22 '24 | Sale | 13.08 | 7,706 | 100,804 | 792,416 | Feb 23 08:27 PM | Avelar Rui | See Remarks | Feb 22 '24 | Sale | 13.08 | 1,821 | 23,821 | 399,891 | Feb 23 08:27 PM | Beaver Sandra | Chief Financial Officer | Feb 22 '24 | Sale | 13.08 | 1,821 | 23,821 | 159,873 | Feb 23 08:27 PM | Parschauer Karah Herdman | Director | Jan 30 '24 | Sale | 13.14 | 11,931 | 156,733 | 31,243 | Feb 02 04:57 PM | MOATAZEDI DAVID | See Remarks | Dec 06 '23 | Sale | 10.09 | 51,348 | 517,891 | 635,244 | Dec 08 06:15 PM | MOATAZEDI DAVID | See Remarks | Dec 08 '23 | Sale | 9.73 | 31,300 | 304,505 | 603,944 | Dec 08 06:15 PM |
|